Entrada Therapeutics, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Entrada Therapeutics, Inc. | TRDA - NASDAQ |
$19.00-$21.00 | $20.00 | $26.50 | 9.075 million | 10/29/2021 |
| Goldman Sachs, Cowen, Evercore ISI | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-10-08 Terms Added 2021-10-25 | ||||||
Entrada Therapeutics, Inc. Quote & Chart - Click for current quote - TRDA
IPO Boutique aggregates information on public companies and private companies, such as "TRDA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Entrada Therapeutics, Inc. (adapted from Entrada Therapeutics, Inc. prospectus):
They aim to transform the lives of patients by establishing Endosomal Escape Vehicle (EEV) therapeutics as a new class of medicines and they aim to become the world’s foremost intracellular therapeutics company.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They aim to transform the lives of patients by establishing Endosomal Escape Vehicle (EEV) therapeutics as a new class of medicines and they aim to become the world’s foremost intracellular therapeutics company.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "TRDA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.